Przejdź do zawartości

Hematologia

Optymalizacja i utrzymanie hemostazy

Rekombinowany aktywowany czynnik VII (rFVIIa)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (opens new window)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Źródło‎: Am J Hematol 2002;69(3):219-22.

Indeks‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (opens new window)

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. (opens new window)

Salama A, Rieke M, Kiesewetter H, von Depka M.

Źródło‎: Ann Hematol 2009;88(1):11-5.

Indeks‎: PubMed 18787824

DOI‎: 10.1007/s00277-008-0608-3

https://www.ncbi.nlm.nih.gov/pubmed/18787824 (opens new window)